To investigate the subcellular distributions of Smad proteins, the intracellular mediators of transforming growth factor-␤ family cytokines, we examined their sequences for nuclear export signals (NES). We found a leucine-rich NES-like motif (termed NES2) in the central linker region of the receptor-regulated Smads that is absent from the other two classes of Smads (Co-Smads and I-Smads). In microinjection assays, NES2 peptide caused nuclear export of a fused glutathione S-transferase protein. Mutations in NES2 converted Smad1 from an even distribution throughout the cells into an exclusive nuclear localization in both transiently and stably expressing cell lines, and this nuclear enrichment was more pronounced than that induced by mutations in NES1. Furthermore, overexpression of CRM1, the cellular export receptor, transforms Smad1 into a mostly cytoplasmic profile by enhancing its nuclear export. The Smad1 NES2 mutant but not the Smad1 NES1 mutant is mostly resistant to this cytoplasmic targeting, indicating that NES2, not NES1, is the major target for CRM1 in Smad1. We further confirmed the functionality of NES2 by a heterokaryon assay. The Smad1 NES1 mutant displays good ligand responsiveness and moderately lowered transcriptional activity compared with wild type Smad1. In contrast, the Smad1 NES2 mutant shows a severe disruption in reporter gene activation, minimal response to bone morphogenetic protein stimulation, and significantly lowered bone morphogenetic proteininduced phosphorylation, which may be the reason for its deficient transcription activity. Thus, we have defined a major NES in Smad1 that is essential for its ligand-induced coupling with cell surface receptors and hence, transcriptional activity. Our study, along with recent studies of the nucleocytoplasmic shuttling of Smad2 and Smad3 proteins, demonstrate that continued nucleocytoplasmic shuttling is a common requisite for the active signaling of R-Smads. Although conserved in other R-Smads such as Smad3, NES2 is not functional in these R-Smads because CRM1 overexpression fails to target them to cytoplasm. Possible reasons for this discrepancy are discussed.
Smad proteins are intracellular mediators of TGF-␤ 1 family cytokines and modulate a variety of important biological processes such as growth control, wound repair, bone morphogenesis, and immune responses. After binding to their respective type II receptors, TGF-␤ family cytokines induce the heterodimerization of type I and type II receptors, resulting in the activation of the kinase activity of type I receptors, which proceeds to phosphorylate Smad proteins at their C termini. This phosphorylation event stimulates nuclear translocation of Smads and their transcriptional activities inside the nucleus (1) .
Smads are classified into three subclasses based on structure and function. Receptor-regulated Smads (R-Smads) directly interact with activated TGF-␤ type I receptors and undergo phosphorylation at the C terminus. This class includes Smad1, -5, and -8, which mediate BMP signaling events, and Smad2 and -3, which mediate TGF-␤ signaling. Co-Smads do not directly bind to the receptors and are not phosphorylated at the C terminus. Rather, they form obligatory partners with RSmads to facilitate signal transduction. The only mammalian member of this class is Smad4. Inhibitory Smads include Smad6 and Smad7 in animal cells. They are generally viewed as antagonistic to TGF-␤ or BMP signaling by competing with R-Smads for binding to activated type I receptors and for complex formation with Smad4. Expression of Smad6 and -7 is up-regulated by TGF-␤ stimulation, thus constituting a negative feedback regulation of its signaling pathways (2) . Smads contain two highly conserved domains: the MH1 domain, located at the N terminus and responsible for DNA binding; and the MH2 domain, located at the C terminus and responsible for transcriptional activation and complex formation between different Smads. These are joined in the middle by a more variable proline-rich linker region whose functions remain unclear. Recently, a nuclear export signal (NES) has been identified in the Smad4 linker region that mediates its nuclear exclusion (3) .
The intracellular distribution of a transcription factor is critical to its functions. The nuclear localization of a protein is usually controlled by two opposing signals: nuclear localization signal (NLS) and NES. NLSs, exemplified by the polybasic T-antigen NLS (monopartite basic NLS) and nucleoplasmin NLS (bipartite basic NLS), are defined as a short peptide motif that is both necessary and sufficient for the nuclear translocation of a protein. Conversely, an NES, such as the leucine-rich NES of HIV Rev protein, is a short sequence that is necessary and sufficient for nuclear export of its host protein. Certain transcription factors are constitutively nuclear because of the presence of an active NLS and the absence of an NES. How-ever, some other transcriptional factors, such as the tumor suppressor p53, contain both an NLS and NES, resulting in their constant shuttling between the nucleus and cytoplasm. The regulation of this shuttling activity constitutes a critical cellular mechanism to modulate the activities of these transcription factors (4 -6) .
Under basal conditions, R-Smads mostly exist in the cytoplasm; upon ligand activation, they undergo C-terminal phosphorylation, which exposes a basic NLS motif in their MH1 domain and results in its nuclear translocation (7) (8) (9) . Smad4 contains an NES in the segment joining the MH1 domain and the linker, which prevents its nuclear accumulation. It can only achieve nuclear localization after forming a complex with active R-Smads, which sequesters the NES (3).
We have previously reported that at steady-state Smad1 is both nuclear and cytoplasmic. BMP addition triggers Smad1 phosphorylation and accumulation in the nucleus. Mutations in the N-terminal basic NLS-like motif of Smad1, conserved among all Smads, eliminated its ligand-induced nuclear translocation without affecting its other functions including DNAbinding or complex formation with Smad4. Overexpression of CRM1, the major nuclear export receptor, resulted in Smad1 relocalization to the cytoplasm and inhibition of BMP-induced nuclear accumulation of Smad1. Conversely, addition of leptomycin B, an inhibitor of Crm1-mediated nuclear export, induced rapid nuclear accumulation of Smad1. Thus, in addition to the NLS, Smad1 also contains a functional NES(s) and is subject to constant nucleocytoplasmic shuttling regardless of ligand stimulation. The steady-state distribution of Smad1, therefore, reflects a balance between the opposing NLS and NES signals. BMP stimulates Smad1 nuclear accumulation by suppressing its nuclear export and tipping the balance in favor of nuclear import (10) .
We identified a C-terminal NES motif (termed NES1) in Smad1 that is functional in driving the nuclear export of a fused GST protein, and mutation of this motif shifts the localization of Smad1 to a partial nuclear profile (10) . However, we now report that NES1 is not the only functional NES in Smad1, because overexpression of CRM1 resulted in relocalization of a Smad1 NES1 mutant to the cytoplasm (see Fig. 1 ), suggesting the existence of another active NES (NES2). Here we report the discovery of NES2 in the adjoining region of Smad1 MH1 and linker domain. Importantly, NES2 appears to be the major NES in Smad1 that is essential for its ligand-induced coupling with cell surface receptors and, hence, its transcriptional activity.
MATERIALS AND METHODS

Cell Lines and Constructs-GFP-tagged
Smad1 was constructed using the Clontech pEGFP-C1 vector, which allows Smad1 fusion to the C terminus of eGFP. Primers corresponding to the N-and C-terminal regions of Smad1 were tagged with BglII and EcoRI sites, respectively, and used in PCR with human Smad1 cDNA as template (Pfu polymerase, Stratagene). The products were confirmed by sequencing, digested with BglII and EcoRI, and subcloned into the pEGFP vector. To generate a retroviral vector encoding a GFP-Smad1 fusion, the pEGFPSmad1 vector was digested with AgeI and SalI and then ligated into a similarly restricted pMX vector to create the pMX-GFP-Smad1 (7). Transfection of this vector allows moderate expression levels of the target protein in mammalian cell lines. BOSC, Mv1LU, or C2C12 cells were transiently transfected using the FuGENE 6 reagent (Roche Diagnostics) according to the manufacturer's instructions. Cells were maintained in DMEM supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin, in 5% CO 2 at 37°C.
Site-directed Mutagenesis-Mutations of specific amino acids in Smad1 NES1, NES2, and Smad3 NES1 and NES2 were carried out with the QuikChange Mutagenesis kit (Stratagene).
Microinjection-Peptides corresponding to wild-type Smad1 NES2 ( 130 VESPVLPPVLV) or mutant NES2 (VESPAAPPAAV) were fused in-frame to the C terminus of GST and expressed in BL21 cells. Various GST-NES fusion proteins were purified at 0.5-1.0 mg/ml concentration in injection buffer (20 mM Hepes-KOH, pH 7.4, 200 mM KCl), combined 1:1 with fluorescein isothiocyanate-dextran (15 mg/ml at 4 mol of fluorescein isothiocyanate/mol of dextran, M r 70,000; Molecular Probes) and injected into the nuclei of 35% confluent 3T3 fibroblast cells using an Eppendorf Injectman system at the Keck Microscope Facility at the Whitehead Institute. After 30 min incubation at 37°C, injected cells were fixed with 4% paraformaldehyde in phosphate-buffered saline and permeabilized with 0.1% Triton X-100. GST-NES fusion proteins were detected with goat anti-GST antibody (Amersham Biosciences) followed by donkey anti-goat secondary antibody-Texas Red conjugate (Molecular Probes).
Luciferase Assays-Twenty-four hours before transfection, Mv1Lu cells or C2C12 cells were seeded in triplicate at 2 ϫ 10 5 cells per well in a 6-well plate. 0.75 g each of 12xGCCG-Luciferase construct (11), 0.5 g of constitutively active ALK3QD, and 0.4 g of indicated Smad1 vectors were co-transfected per well using FuGENE 6 (Roche Diagnostics). 0.3 g of pSV␤ (Clontech), encoding ␤-galactosidase, was included in each sample to control for transfection efficiency. Thirty-six hours after transfection, luciferase and ␤-galactosidase activity were measured as described previously (7) .
Heterokaryon Nucleocytoplasmic Shuttling Assay-Human HeLa cells and mouse NIH 3T3 cells were separately cultured in DMEM supplemented with 10% fetal bovine serum. HeLa cells were first transfected with GFP-Smad1 constructs by FuGENE 6 (Roche Diagnostics). Twenty-four hours post-transfection, HeLa cells were mixed with an equal number of NIH 3T3 cells and seeded onto 6-well plates. After overnight incubation, 100 g/ml cycloheximide was added to the culture medium to inhibit protein synthesis. After 1-2 h, the co-cultured cells were washed twice with phosphate-buffered saline and fused with 50% polyethylene glycol 3500 (Sigma) in serum-free medium for 1-2 min, washed twice with medium containing 100 g/ml cycloheximide, and incubated in DMEM plus 100 g/ml cycloheximide for another 1 h before fixation. Before visualization under fluorescence microscope for the GFP signal, the cells were counterstained with Hoechst 33258 (Sigma) to distinguish between HeLa and 3T3 cell nuclei.
Smad1 Immunoprecipitation and Phosphoserine Immunoblot-COS-7 cells were transfected with GFP-Smad1 WT or NES2
Ϫ . 24 h post-transfection, cells were starved in DMEM plus 0.5% fetal bovine serum for 4 -6 h and then treated with 100 ng/ml BMP-4 for 1 h. Cells were then lysed in lysis buffer plus phosphatase inhibitors (1% Nonidet P-40, 50 mM Tris-HCl (pH 7.5), 50 mM NaF, 50 mM glycerophosphate, 2 mM EDTA, 10% glycerol plus complete protease inhibitor mixture (Roche Diagnostics)) with NaCl adjusted to 400 mM). After centrifugation, clarified lysates were diluted 1:1 with water and immunoprecipitated with goat anti-Smad1 antibody (Santa Cruz Biotechnology). 20 -30 l of protein G-Sepharose (Amersham Biosciences) was then added to recover the immune complex, which was resolved on SDS-PAGE and transferred onto a polyvinylidene difluoride membrane. Total GFP-Smad1 in the immunoprecipitate was displayed by anti-GFP immunoblot, serine-phosphorylated Smad1 was revealed with antiphosphoserine antibody (Zymed Labs, San Francisco, CA).
RESULTS
Smad1 Contains a Second NES in the Linker Region-
Smad1 shuttles continuously between the nucleus and cytoplasm and contains a leucine-rich NES near its C terminus (termed NES1) that is conserved among R-Smads and CoSmads but not I-Smads (10) . A GFP fusion of WT Smad1 transiently expressed in BOSC cells is uniformly distributed throughout the cells (Fig. 1, panel 1 ). The best characterized nuclear export pathway uses a leucine-rich NES, which is recognized by the export receptor CRM1. Co-expression of Crm1 resulted in the cytoplasmic redistribution of GFP-WT Smad1, suggesting the presence of a Crm1-dependent NES in Smad1 (10) . Importantly, mutation of the previously identified NES1 ( 406 LTKMCTIRM 3 406 ATKACTIRM, Smad1 NES1 Ϫ ) resulted in a nuclear enrichment of Smad1 (10 Fig. 1, panel 3) . However, overexpression of CRM1 still promoted relocalization of Smad1 NES1
Ϫ to the cytoplasm (panel 4), indicating that there is another functional NES in Smad1. GFP itself was uniformly distributed between the nucleus and cytoplasm and did not relocalize on CRM1 coexpression (panels 5 and 6).
To identify the other NES(s) in Smad1, we scanned its sequence and noticed a leucine-rich NES-like motif in the Nterminal region of the central linker:
130 VESPVLPPVLV; large hydrophobic residues that are presumably critical for the export functions are underlined. Multiple sequence alignment ( Fig. 2) demonstrates that this NES motif (termed "NES2") is well conserved among the mammalian R-Smads of both the BMP and TGF-␤ pathways (Smad1, -2, -3, and -5) as well as invertebrate R-Smad homologues such as Drosophila MAD and Caenorhabditis elegans Sma-2 (data not shown). However, ISmads such as Smad6 and -7 lack the second half of this motif including the last three large hydrophobic residues (VLV). Also, despite the fact that NES2 is located in the region of R-Smads that corresponds to that of the Smad4 NES, it is clearly absent from the Co-Smads such as Smad4 and Medea (not shown, Drosophila Smad4 orthologue), which contain a distinct NES. Because NES2 maps to the region joining the MH1 domain and central linker, this may confer greater flexibility and accessibility for its interaction with other proteins. In the Smad3 MH1 domain crystal structure (13), the NES2 is at the extreme C terminus of the segment and appears disordered.
NES2 Is Functional in a Microinjection Assay-To confirm that Smad1 NES2 behaves as a nuclear export signal, we first studied its export ability in a microinjection assay (Fig. 3A) . This assay has been previously used to demonstrate the export capacities of various NES signals (14) . Changing the large hydrophobic residues of many CRM1-dependent NESs to alanine disrupts the export functions of the NES (15, 3) . Because NES2 contains two groups of hydrophobic residues:
130 VESPV-LPPVLV (underlined), we mutated both groups of "VL" to alanines to eliminate the presumed export functions of NES2 ( 130 VESPVLPPVLV 3 VESPAAPPAAV). GST fusion proteins with either WT NES2 or mutant NES2 were purified and injected into the nuclei of NIH 3T3-L1 cells. As controls, a GST fusion with the NES of HIV Rev protein was excluded from the nucleus (panels 1 and 2), whereas a GST fusion with a mutated version of the Rev NES (M10), known to be inactive in nuclear export (14) , was not exported (panels 3 and 4), validating the injection assay. A GST fusion with the Smad1 NES2 peptide showed complete nuclear export (panels 5 and 6), whereas a GST fusion with the mutant NES2 was mostly retained within the nucleus (panels 7 and 8), demonstrating the export activity of NES2. Notably, in our system, over 85% of cells injected with GST-Rev NES displayed nuclear export, compared with 57% of cells injected with GST-Smad1 NES2 (the others showed partial nuclear extrusion, Fig. 3A, inset) . This suggests that the Smad1 NES2 may constitute a weaker NES than the Rev NES in this assay system.
NES2 Is the Major NES in Smad1-To confirm that the identified NES2 is functional not only in GST fusion proteins but also in the context of intact Smad1 protein in vivo, we transiently expressed several NES-mutated GFP-Smad1 fusions in 293T cells (Fig. 3B) . At steady-state, Smad1 is distributed throughout the cells, whereas the Smad1 NES1
Ϫ is more nuclear than cytoplasmic (Fig. 3B, panels 1 and 3) . In contrast, the Smad1 NES2 Ϫ was exclusively nuclear (panel 5) with the extent of nuclear accumulation more pronounced than that of Smad1 NES1
Ϫ (compare panel 5 with panel 3). More importantly, whereas CRM1 co-expression relocalized both WT Smad1 and the Smad1 NES1
Ϫ to the cytoplasm, the nuclear profile of Smad1 NES2
Ϫ was mostly unperturbed by the co- 
FIG. 2. NES2 is conserved among R-Smads but not in Co-Smads or I-Smads.
A, schematic representation of Smad1 primary structure highlighting the linker region and the highly conserved MH1 and MH2 domains. The locations of its NLS, NES1, and NES2 are indicated. B, the regions between MH1 and linker domains from all three classes of Smads: R-Smads (Smads1, -2, and -3), and Co-Smads (Smad4), and I-Smads (Smad6 and -7) were aligned with the ClustalX program and displayed. Identical residues are shaded yellow and similar residues are boxed. The Co-Smad NES and R-Smad NES2 are both indicated, and the large hydrophobic residues within the NES motifs are indicated by "*".
FIG. 3. NES2 is the major NES in Smad1.
A, NES2 is functional in microinjection assays. GST fusions with the peptide corresponding to Smad1 NES2 (VESPVLPPVLV) or a mutant version (VESPAAPPAAV) were purified and injected into the nuclei of 35% confluent NIH 3T3 cells. Fluorescein isothiocyanate (FITC)-labeled dextran was co-injected as injection site marker. HIV Rev protein NES and its inactive mutant (M10) were included as controls for the test. After 37°C incubation for 30 min, cells were fixed and stained with goat anti-GST antibody followed by donkey anti-goat Texas Red. Cells were then imaged for both fluorescein isothiocyanate (dextran) and Texas Red (GST). The inset bar graph is a expression of CRM1 (compare panel 6 with panels 2 and 4). Quantitative analysis of the CRM1 overexpression results indicates that in cells expressing WT Smad1, 96% showed cytoplasmic distribution; and in cells expressing the Smad1 NES1 Ϫ , 86% displayed cytoplasmic localization. In contrast, among the cells expressing the Smad1 NES2 Ϫ , only 17% showed a predominantly cytoplasm profile (Fig. 3C) , indicating that NES2 is the major NES in Smad1. Interestingly, when only the first pair of hydrophobic residues ( 134 VL) in NES2 were mutated to alanines ( 130 VESPVLPPVLV 3 VESPAAP-PVLV: Smad1 NES2/ 134 VL 3 AA), or only the second pair of hydrophobic residues ( 138 VL) were mutated to alanines ( 130 VESPVLPPVLV 3 VESPVLPPAAV: Smad1 NES2/ 138 -VL 3 AA), Smad1 also became mostly nuclear (Fig. 3B, panels  7 and 9) . However, compared with Smad1 NES2 Ϫ , these partial mutants showed increased CRM1 sensitivity (Fig. 3, B, panels  8 and 10, and C) , suggesting that changing only one pair of VL residues results in incomplete destruction of NES2 export functions.
The expression levels of the Smad1 NES1 Ϫ and NES2 Ϫ were similar to that of WT Smad1, and CRM1 co-expression did not significantly influence these levels (Fig. 3B, inset, upper panel) . The expression levels of the partial NES2 mutants (Smad1 NES2/ 134 VL 3 AA and NES2/ 138 VL 3 AA) were also analyzed and found to be similar to that of WT Smad1 (data not shown). Additionally, the CRM1 immunoblot revealed low levels of CRM1 in cells transfected with Smad1 alone, representing the endogenous CRM1 protein. It also showed enhanced CRM1 levels in cells co-transfected with CRM1 (Fig. 3B, inset, Ϫ accumulates in the nucleus, which may be caused either by disruption of its nuclear export or by newly acquired interactions with nuclear resident proteins. If the nuclear enrichment of Smad1 NES2
Ϫ is caused by disruption of an existing NES in Smad1, its nuclear localization could be reversed by the addition of an exogenous NES. However, if it is because of nuclear retention, addition of a new NES is unlikely to reverse the observed nuclear accumulation. To distinguish between these two possibilities, we fused the previously characterized Smad4 NES sequence, "GIDLSGLTLQ" (critical leucine or leucine-like residues underlined, Refs. 3 and 9), to the N terminus of Smad1 NES2
Ϫ and investigated its distribution profile (Fig. 3D) . The N-terminal fusion was chosen because C-terminal fusion may block the ligand-induced phosphorylation of Smad1 C-terminal serine residues and render it functionally inactive (16) . In contrast to its original nuclear profile, fusion of the Smad4 NES to Smad1 NES2 Ϫ resulted in the redistribution of the protein to the cytoplasm (panel 2). Addition of leptomycin B, a drug that specifically inactivates Crm1, results in the nuclear accumulation of the protein (panel 3), indicating that the cytoplasmic localization of the fusion protein is because of active nuclear export. This proves that the nuclear enrichment of Smad1 NES2 Ϫ is because of the disruption of a pre-existing NES. It also implies that Smad4 NES is stronger than the Smad1 NES2, because WT Smad1 is distributed throughout the cells while Smad4 NES fusion to Smad1 NES2 Ϫ is mostly nuclear-excluded. Ϫ can be reversed by addition of Smad4 NES. Smad4 NES sequence (GIDLSGLTLQ) was fused in-frame to the N terminus of Smad1 and the fusion protein was further tagged by GFP at the N terminus. This construct, Smad1 NES2 Ϫ (Smad4 NES), and the original Smad1 NES2
Ϫ were transiently expressed in HeLa cells. GFP fluorescence was recorded on live cells (panels 2 and 1, respectively). Leptomycin B (LMB) was then added to cells expressing Smad1 NES2
Ϫ (Smad4 NES) for 1 h to ascertain if the fusion protein is subject to nuclear export (panel 3). E, Smad1 NES2
Ϫ remains mostly nuclear under stable expression conditions. Smad1 WT and Smad1 NES2 Ϫ were subcloned into the retroviral pMX vector and transfected into BOSC cells. Cell media were collected for infection of MvLu1 cells expressing mouse ecotropic receptor (L20). After 2 days, infected cells were checked under the fluorescence microscope for GFP-Smad1 localization.
To ascertain that the constitutive nuclear accumulation of Smad1 NES2 Ϫ is not complicated by transient overexpression, we expressed it in a stable Mv1LU cell line so that the GFPSmad1 expression level would be more similar to that of the endogenous Smad1 (about 3-fold overexpression) (Fig. 3E) . Consistent with Fig. 3B , the WT GFP-Smad1 fusion appears throughout the cells, whereas GFP-Smad1 NES2 Ϫ was mostly nuclear.
Nucleocytoplasmic Shuttling of the Smad1 MH1 Domain Further Confirms the Functionality of NES2-Although NES2 is located in the C-terminal region of the Smad1 MH1 domain, the isolated Smad1 MH1 domain is predominantly nuclear at steady-state because of the existence of an N-terminal basic NLS ( 43 KKLKKKK, Ref. 10). Therefore, the Smad1 MH1 domain may actively shuttle between the nucleus and cytoplasm driven by the NLS and NES2 signals in a ligand-independent manner. To confirm this, we employed a heterokaryon shuttling assay (17) .
HeLa cells were transfected with GFP-Smad1 MH1 domain, which is exclusively nuclear, and then fused with untransfected mouse 3T3 cells (Fig. 4) . Nuclei of 3T3 cells can be easily distinguished from the HeLa cell nuclei by their stippled appearance after Hoescht staining. If Smad1 MH1 does shuttle, the GFP signal will be found in both HeLa and 3T3 nuclei. If Smad1 MH1 domain is not subject to nucleocytoplasmic shuttling, the GFP signal will be restricted to HeLa cell nuclei and absent from 3T3 cell nuclei. In fact, the GFP-Smad1 MH1 domain was also found in the 3T3 cell nuclei, indicating that the Smad1 MH1 domain can exit the original HeLa cell nuclei and then enter the 3T3 cell nuclei, thus establishing its shuttling ability (Fig. 4, panels 1-3, 4 -6, and 7-9) .
To ascertain if NES2 mediates the nuclear export of the Smad1 MH1 domain during the shuttling, we mutated NES2 in the Smad1 MH1 domain in the same way as we mutated NES2 in full-length Smad1 (Fig. 3) . Strikingly, this mutation eliminated the translocation of Smad1 MH1 domain into the 3T3 cell nuclei (panels a-c), confirming that NES2 is responsible for the nuclear export of the Smad1 MH1 domain. Quantitative analysis of over 70 GFP-positive HeLa-3T3 fusion cells showed that in 74% of the cases, Smad1 MH1 NES2
Ϫ was confined to the HeLa cell nuclei and only 26% of cells displayed limited translocation into the 3T3 nuclei. In comparison, among the HeLa-3T3 fusion cells expressing WT Smad1 MH1, less than 5% showed exclusive HeLa nuclei staining, whereas 95% of the cells showed signal in both HeLa and 3T3 nuclei (data not shown). Because full-length Smad1 NES2
Ϫ is mostly nuclear under steady-state conditions, we also tested its shuttling ability (panels d-f). Not surprisingly, Smad1 NES2 Ϫ fails to shuttle from the HeLa cell nuclei into 3T3 cell nuclei, again corroborating the importance of NES2 in Smad1 nuclear export. Because WT Smad1 is not predominantly nuclear, we were not able to test its shuttling ability with this assay.
NES2 Is Required for Smad1 Transcriptional Activity in Response to BMP Stimulation-Next we tested the transcriptional activity of the Smad1 NES2
Ϫ to assess the role NES2 plays in Smad1 signaling. We transfected Mv1Lu cells or C2C12 cells with WT Smad1 or its various NES mutant constructs and the Smad1/Smad5-specific 15xGCCG-luciferase reporter (11), together or not with the constitutively active BMP type IA receptor (ALK3 Q204D) to mimic the presence or absence of BMP stimulation (Fig. 5) . In C2C12 cells (Fig. 5A) , compared with vector-transfection control, WT Smad1 transfection induced a 1-fold increase of basal reporter activity and a 3.5-fold increase of ALK3-induced reporter gene activity. In line with our previous study (10), Smad1 NES1
Ϫ still partially responded to receptor activation (reporter gene activity is about 70% higher with activated ALK3 than without, compare the black and white columns), even though it is partially defective in overall reporter gene activity. In contrast, the Smad1 NES2 Ϫ is mostly inactive in reporter gene activation and shows minimal responsiveness to receptor activation (no increase of black column over the white column). In Mv1LU cells (Fig. 5B) , essentially the same results were obtained: Smad1 NES2
Ϫ is more defective than Smad1 NES1
Ϫ . Additionally, in Mv1LU cells, we tested the synergistic effect of Smad1 with Smad4 in reporter gene activation. WT Smad1 and Smad4 together produced a dramatic increase of transcriptional activity upon receptor activation, which was also significantly decreased by the Smad1 NES2 mutation. Taken together, these results showed that constitutive nuclear localization of Smad1 not only failed to confer ligand-independent transcriptional activity, but actually eliminated ligand-induced transcriptional activation.
Smad1 NES2 Ϫ Shows Significantly Decreased Phosphorylation in Response to BMP-4 -We reasoned that the low transcriptional activity of Smad1 NES2
Ϫ in response to ligand might be because of its inability to access the cell surface type I BMP-receptors (BMPR-IA and -IB) because of its constitutive nuclear confinement and failure to shuttle out of the nucleus
FIG. 5. Smad1 NES2
؊ is transcriptionally defective. Mv1Lu cells (A) or C2C12 cells (B) were seeded in triplicate at 2 ϫ 10 5 cells per well in a 6-well plate 24 h prior to transfection. 0.75 g each of 15xGCCG-luciferase construct (11), 0.5 g of constitutively active ALK3 Q204D, and 0.5 g of indicated Smad1 vectors were co-transfected per well. 0.3 g of pSV␤ (Clontech), encoding ␤-galactosidase, was included in each sample to control for transfection efficiency. Thirty-six hours after transfection, luciferase and ␤-galactosidase activity were measured as described previously (10) . Plotted is the ratio of luciferase activity to ␤-galactose activity. (Fig. 4) . Ligand-induced phosphorylation of R-Smads by their cognate cell surface receptors constitutes a critical first step in their activation process (1) . To study if Smad1 NES2
Ϫ is defective in ligand-induced phosphorylation, we transfected BMPresponsive COS-7 cells with Smad1 WT or NES2 Ϫ (both as GFP fusions). The cells were then treated with BMP-4 to stimulate Smad1 phosphorylation (Fig. 6A) . Smad1 proteins were immunoprecipitated with an anti-Smad1 antibody and immunoblotted with either GFP antibody to reveal the total Smad1 protein levels, or with anti-phosphoserine antibody to display the amount of Smad1 that has undergone serine phosphorylation. A similar approach has been used previously to demonstrate Smad1 activation in osteoblasts and chondroblasts (18) . GFP-Smad1 WT showed minimal serine phosphorylation prior to ligand stimulation and greatly increased phosphorylation with BMP-4 treatment (29.7-fold increase over basal, Fig. 6,  lanes 1-2) . In contrast, GFP-Smad1 NES2 Ϫ only displayed a mere 4.5-fold increase in its phosphorylation level after ligand stimulation (lanes 3 and 4) . This suggests that the constitutive nuclear localization of Smad1 NES2
Ϫ severely restricted its physical interaction with cell surface type I BMP receptors, possibly explaining its defective transcriptional activity. The remaining 4.5-fold stimulation probably comes from a small pool of cytoplasmic Smad1 NES2
Ϫ that can still couple to BMP receptors.
DISCUSSION
NES2 Is the Major NES in Smad1-We previously showed that Smad1 contains both an NLS and a NES and is subject to constant nucleocytoplasmic shuttling. We also identified a Cterminal NES (NES1) in Smad1 whose mutation shifted Smad1 to a partial nuclear localization even in the absence of ligand stimulation (10) .
Here we demonstrate the presence of a second functional leucine-rich NES, NES2, in the linker region of Smad1. It conferred nuclear exclusion to a fused heterologous protein; additionally, mutation of this motif caused constitutive nuclear accumulation of Smad1 in various cell lines under different expression levels. Although both NES1 and NES2 are capable of mediating the nuclear exclusion of a fused GST protein (Ref. 10 ; Fig. 3A) , NES2 seems to be the major NES in Smad1. This is most clearly demonstrated by the CRM1 coexpression study: both WT Smad1 and Smad1 NES1
Ϫ are relocalized to the cytoplasm by CRM1 overexpression, but Smad1 NES2
Ϫ is largely resistant to CRM1-mediated nuclear export. The dominant nature of NES2 over NES1 may be because of the different accessibilities of each signal in the context of the threedimensional structure of Smad1.
Is Smad1 NES2 Also Functional in Other R-Smads?-Because Smad1 NES2 is conserved in other R-Smads such as Smad2 and Smad3, it may also be functional in Smad2 and Smad3. However, we have previously shown that CRM1 overexpression does not cause either cytoplasmic targeting of Smad3 or inhibition of the ligand-induced nuclear translocation of Smad3 (10) . This indicates that unlike Smad1, Smad3 may not use a classical NES/CRM1 pathway for nuclear export. In line with this observation, Inman et al. (19) and Xu et al. (20) have recently reported that Smad2 and Smad3 are subject to nucleocytoplasmic shuttling independent of CRM1.
We speculate that in contrast to Smad1 NES, the NES in TGF-␤ pathway Smads such as Smad2 or Smad3 are inactive. This is additionally confirmed by the following GST fusion protein binding assay (see Supplementary Materials Fig. 1 ): GST fusions to either Smad1 full-length protein or Smad1 MH1 domain bound to endogenous CRM1 proteins in HeLa cell lysates; furthermore, this binding is diminished by leptomycin B incubation. In comparison, Smad3 failed to interact with CRM1, demonstrating that even though it contains a homologous NES2, the signal is not recognized by CRM1.
Based on this finding, we propose the following theory to explain the apparent inactivity of Smad3 NES2. It is not surface-exposed or, there are other competing Smad3-binding proteins in HeLa cell lysate that may bind to the same region and exclude CRM1 interaction. The crystal structure of Smad3 but not the Smad1 MH1 domain is available (13) . The Smad3 NES2 motif appears as a structurally undefined loop, probably because it is located at the extreme C terminus of the Smad3 MH1 domain construct used in the paper, thus we are still not clear about its structural features in intact Smad3 protein. We postulate that in Smad1, this region is surface-exposed and hence accessible for CRM1 recognition, whereas in intact Smad3, it is either internally folded, or, more likely, it is masked by Smad3-binding factors, both of which will exclude the signal from binding to CRM1. It has been previously shown that Smad3 binds to importin ␤ through its MH1 domain (8, 21) ; also, Smad3 but not Smad1 have been found to bind to tubulin in the cytoplasm (22); additionally, TFE-3, ATF-2, HEF 1, Jun, and Lef1/Tcf preferentially bind to the Smad3 MH1 domain but not to Smad1 MH1 (23) . These proteins could all be
؊ is defective in ligand-induced phosphorylation. COS-7 cells were transfected with GFP-Smad1 WT or NES2 Ϫ and starved in DMEM with 0.5% fetal bovine serum for 4 -6 h. Cells were treated or not with 100 ng/ml BMP-4 for 1 h. The cells were then lysed and Smad1 was immunoprecipitated with goat anti-Smad1 antibody (Santa Cruz Biotechnology). 20 -30 l of protein G-Sepharose was then added to recover the immune complex, which was resolved on SDS-PAGE and transferred onto polyvinylidene difluoride membrane. Total GFP-Smad1 in the immunoprecipitate was displayed by anti-GFP immunoblot, and serine-phosphorylated Smad1 was revealed with antiphosphoserine antibody (Zymed Laboratories Inc.).
candidates responsible for excluding Smad3 from interaction with CRM1.
Efficient Nucleocytoplasmic Shuttling of Smad1 Conferred by NES2 Is Critical for Its Transcriptional Activity-The
Smad1 NES2
Ϫ mutant displays minimal transcriptional activity and more importantly, it is essentially non-responsive to receptor activation, suggesting a complete uncoupling from cell surface receptors (Fig. 5) . This was subsequently confirmed by the BMP-induced Smad1 phosphorylation assay, which shows a significant decrease of Smad1 NES2
Ϫ phosphorylation in response to BMP-4 (Fig. 6) .
In light of this result, we propose that the efficient nucleocytoplasmic shuttling of Smad1 is necessary for its transcriptional activation, and this shuttling is largely disrupted by the Smad1 NES2 mutation. Our results suggest that nuclear-localized Smad1 will recycle back to the cytoplasm because of their intrinsic nuclear export ability. This will re-expose it to the active receptors on plasma membrane, thus re-establishing another round of phosphorylation-induced nuclear translocation and target gene activation. We speculate that the recycling of the nuclear Smad1 to the cytoplasm is preceded or accompanied by the dephosphorylation of their C-terminal serine residues that have been phosphorylated by the BMP receptors during the last round of signaling event, which necessitates their renewed interaction with cell surface receptors for continued signaling. This theme is consistent with the theories proposed by Inman et al. (19) and Xu et al. (20) in their recent studies, arguing that the active signaling of Smad2 and Smad3 requires continuous nucleocytoplasmic shuttling.
Another reason for the deficient transcriptional activity of Smad1 NES2
Ϫ may be that Smad1 needs certain DNA-binding co-factors or transcriptional co-activators (23) , and Smad1 phosphorylation would be a prerequisite to establish such interactions. Because of its reduced phosphorylation level, Smad1 NES2
Ϫ may be defective in recruiting these necessary co-factors. It was found previously that Smad1 displays ligandinduced binding to the universal transcriptional co-activator, p300 (24) . It will be interesting to determine whether transcription of the 12xGCCG luciferase reporter assay we employed here to test Smad1 function also requires the interaction of Smad1 with p300, and if so, whether Smad1 NES2 Ϫ exhibits diminished binding to p300.
Nucleocytoplasmic Shuttling Is a General Property of R-Smads and Co-Smads-We conclude that subcellular localization of Smad1 is determined by the balance between two opposing signals: nuclear import driven by the NLS in their MH1 domain, and nuclear export driven by the NES1 and NES2. It is a dynamic equilibrium that will either shift to a nuclear or cytoplasmic distribution depending on the cellular context: enhancement of import or inhibition of export will lead to nuclear enrichment; on the other hand, enhancement of export or inhibition of import will result in nuclear exclusion. Although NES2 is the major NES, disruption of either one will tip the balance to the side of nuclear import, resulting in partial (NES1 Ϫ ) or complete (NES2 Ϫ ) nuclear accumulation of Smad1. Our work, along with previous studies of Smad2, Smad3, and Smad4, has established that nucleocytoplasmic shuttling is a common property of the R-Smads and Co-Smads despite the fact that they achieve this through different mechanisms. This process represents an important and potentially much more efficient alternative to other previously identified mechanisms such as ubiquitin-mediated proteasomal degradation in regulating Smad-signaling.
